Jeremy P Tervo Selected Research

elexacaftor

12/2023	Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy.
12/2023	Olfaction, body mass index, and quality of life with cystic fibrosis combination therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeremy P Tervo Research Topics

Disease

3	Cystic Fibrosis (Mucoviscidosis) 04/2024 - 12/2023
1	Nasal Polyps (Nasal Polyp) 12/2023

Drug/Important Bio-Agent (IBA)

2	elexacaftorIBA 12/2023 - 12/2023
2	ivacaftor drug combination tezacaftorIBA 12/2023 - 12/2023

Therapy/Procedure

3	Therapeutics 04/2024 - 12/2023